跳至主要内容
临床试验/CTRI/2025/06/089312
CTRI/2025/06/089312进行中(未招募)不适用

Evaluate the Clinical Effectiveness of the Ayurvedic Formulation Acidogrit in the Management of Functional Dyspepsia:Prospective,Open Label,Single Arm, Observational Study.

Patanjali Research Foundation3 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2025年7月21日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
63
试验地点
3
主要终点
Change in Global Overall Symptom Scale

研究概览

简要总结

This open label, single arm, prospective observational study will assess the effectiveness of Acidogrit in Functional Dyspepsia patients. Patients will be screened on the basis of Inclusion/Exclusion criteria and enrolled after obtaining written Informed consent. The Patients will be followed-up for the next 30 days from the day of enrolment. Primary and secondary outcome will be evaluated by assessing Global Overall Symptom Scale and  Short Form-Nepean Dyspepsia Index

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Diagnosis of functional dyspepsia/ Postprandial Distress Syndrome (PDS) and Epigastric Pain Syndrome by fulfilling Rome IV criteria Written informed consent signed by patient and willing to comply with the study procedure.

排除标准

  • Subjects having a history of structural disease of Oesophagus Stomach and duodenum.
  • Subjects having a history of previous abdominal surgery.
  • Subjects with any active GI Bleeding epigastric mass and peptic ulcer.
  • Chronic alcoholics and habitual tobacco chewers or any substance abuse.
  • Pregnant and lactating women.
  • Any condition the investigator identifies that can confound the participants ability to participate in the study properly.

结局指标

主要结局

Change in Global Overall Symptom Scale

时间窗: Baseline to Day 30.

次要结局

  • Change in Short Form-Nepean Dyspepsia Index(Baseline to Day 30.)

研究者

申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Dr Preeti Rajpoot

Patanjali Wellness

研究点 (3)

Loading locations...

相似试验